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Abstract MI-D (4-phenyl-5-(4-nitro-cinnamoyl)-1,3,4-thiadi-
azolium-2-phenylamine chloride), a new mesoionic compound,
depressed the phosphorylation efficiency of liver mitochondria as
deduced from an accentuated decrease of the respiratory control
coefficient and ADP/O ratio. Analysis of segments of the
respiratory chain suggested that the MI-D inhibition site is
further on than complex I and between complexes II and III. The
transmembrane electrical potential (vi) was collapsed dependent
on MI-D concentration. ATPase activity was dramatically
increased by MI-D in intact mitochondria, but inhibited in
carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP)-
uncoupled mitochondria. These results suggest that MI-D acts
as an uncoupler agent, a property closely related to its structural
characteristics.
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1. Introduction
Mesoionic compounds such as sydnones, sydnonimines, iso-
sydnones, and mesoionic 1,3,4-thiadiazoles possess structural
features, which confer on them potential biological activity
and pharmaceutical use [1^5]. Their structures having well
separated regions of positive and negative charge, associated
with a polyheteroatomic system, enable them to interact with
biomolecules, such as DNA and proteins. Although the mol-
ecules are internally charged, they are neutral overall, and
therefore can cross biological membranes in vivo [6].
A number of mesoionic compounds have also been exam-
ined in the search for anticancer agents [7^9]. Recently, Gryn-
berg et al. [10] synthesized a new one, the 4-phenyl-5-(4-nitro-
cinnamoyl)-1,3,4-thiadiazolium-2-phenylamine chloride (MI-
D; Fig. 1), that was shown to enhance survival of Ehrlich
and S-180 tumor-bearing mice, preventing the growth of the
tumor, with no signi¢cant concomitant alterations in the
hematological parameters in test animals.
In spite of the di¡erent types of biological activity that have
been assigned to mesoionic compounds, much of their bio-
logical and toxicological action mechanisms at molecular
and cellular levels remain to be elucidated. Considering that
the liver is a target organ for toxic e¡ects caused by several
xenobiotics and the important anti-tumoral e¡ect of MI-D
demonstrated by Grynberg et al. [10], ampli¢cation of knowl-
edge about this mesoionic compound is of interest. We there-
fore describe here the e¡ect of MI-D on some energy-linked
functions in isolated rat liver mitochondria.
2. Materials and methods
2.1. Materials
Safranine O, carbonyl cyanide m-chlorophenylhydrazone (FCCP),
sodium succinate, sodium glutamate, rotenone, bovine serum albumin
(BSA), N-2-hydroxyethylpiperazine-NP-2-ethanesulfonic acid (HE-
PES), mannitol, sucrose, phosphoenolpyruvate (PEP), pyruvate kin-
ase, lactate dehydrogenase and NADH were obtained from Sigma (St.
Louis, MO, USA). All other reagents were commercial products of
the highest available purity grade. MI-D (4-phenyl-5-(4-nitro-cinna-
moyl)-1,3,4-thiadiazolium-2-phenylamine chloride) was synthesized in
the Department of Chemistry of the Rural Federal University of Rio
de Janeiro, Brazil, as described [10]. Its structure was con¢rmed by
1H-NMR, 13C-NMR and mass spectrometry [10]. For use in mito-
chondrial assays, MI-D was dissolved in dimethylsulfoxide (DMSO)
and then further diluted with the assay medium.
2.2. Animals
These were male albino rats (Wistar strain, 220^300 g), which re-
ceived a standard laboratory diet (Purina). All animals were starved
12 h before being sacri¢ced; none of them were found to have any
gross pathological lesions.
2.3. Preparation of rat liver mitochondria
Mitochondria were isolated from rat liver by the method of Voss et
al. [11], using an extraction medium consisting of 250.0 mM mannitol,
10 mM HEPES-KOH, pH 7.2, 1.0 mM ethylene glycol-bis(L-amino-
ethylether)-N,N,NP,NP-tetraacetic acid (EGTA) and 0.1 g% BSA. Only
mitochondrial preparations, with respiratory control above 4.0, were
used. Disrupted mitochondria were obtained by a freeze-thawing
treatment and used to determine the activities of enzymes linked to
the respiratory chain and ATPase. MI-D was incubated for 2 min
with the mitochondrial preparations before initiation of the assays.
For each one to be valid, duplicate solvent controls with DMSO were
included. DMSO, in the concentrations used in these experiments, had
no e¡ect on mitochondrial properties.
2.4. Oxygen uptake
Oxygen uptake and oxidative phosphorylation were evaluated at
30‡C in a 1.3-ml thermostatically controlled water-jacketed closed
chamber with magnetic stirring. Oxygen consumption was measured
polarographically using a Clark-type electrode with a Gilson oxy-
graph [12,13]. The reaction medium containing 125.0 mM mannitol,
FEBS 21180 30-11-98
0014-5793/98/$19.00 ß 1998 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 8 ) 0 1 4 2 7 - 6
*Corresponding author. Fax: (55) (41) 2662042.
E-mail: mbmo@bio.ufpr.br
Abbreviations: HEPES, N-2-hydroxyethylpiperazine-NP-2-ethanesul-
fonic acid; EGTA, ethylene glycol-bis(L-aminoethylether)-N,N,NP,NP-
tetraacetic acid; BSA, bovine serum albumin; PMS, N-methyldiben-
zopyrazine methyl sulfate; Tris, tris(hydroxymethyl)aminomethane;
PEP, phosphoenolpyruvate; CCCP, carbonylcyanide-m-chlorophenyl-
hydrazone; FCCP, carbonylcyanide p-trifluoromethoxyphenylhydra-
zone ; DNP, 2,4-dinitrophenol ; vi, transmembrane electrical
potential; DMPC, dimyristoylphosphatidylcholine; DMSO, dimethyl-
sulfoxide; DPIP, 2,6-dichlorophenolindophenol; Pi, inorganic phos-
phate
FEBS 21180FEBS Letters 440 (1998) 46^50
65.0 mM KCl, 10.0 mM HEPES-KOH, pH 7.2, 0.1 mM EGTA and
0.1 g% BSA, was supplemented either with 10.0 WM rotenone, 0.8
mM inorganic phosphate (Pi), 0.08 mM ADP, 3.0 mM sodium succi-
nate and 0.5 mg of mitochondrial protein, or 1.6 mM Pi, 0.16 mM
ADP, 5.0 mM sodium glutamate and 2.0 mg of mitochondrial pro-
tein. The respiratory rate is expressed as nmols of oxygen consumed
per min per mg of mitochondrial protein, according to Estabrook [14].
2.5. Measurements of activities of the enzymatic complex of the
respiratory chain
NADH oxidase, NADH dehydrogenase and succinate dehydrogen-
ase activities were assayed spectrophotometrically [15]. Succinate ox-
idase activity was evaluated polarographically according to Singer
[15]. NADH-cytochrome c reductase and succinate cytochrome c re-
ductase activities were measured by reduction of cytochrome c at 550
nm as described by Somlo [16]. The activity of cytochrome c oxidase
was evaluated according to Mason et al. [17].
The activity of ATPase in broken and intact mitochondria was
evaluated as described by Pullman et al. [18], but with modi¢cations.
In disrupted mitochondria the enzyme was assayed at 37‡C, using a
system consisting of 170.0 mM mannitol, 50.0 mM tris(hydroxymeth-
yl)aminomethane (Tris)-HCl, pH 7.4, 3.0 mM magnesium acetate,
30.0 mM potassium acetate, 1.0 mM PEP, 4.0 U pyruvate kinase,
3.0 U lactate dehydrogenase, 0.2 mM NADH, 3.0 mM ATP, and
100.0 Wg of mitochondrial protein. Results are expressed as nmols
of Pi liberated per min per mg, considering that 1.0 nmol of oxidized
NADH corresponds to 1.0 nmol of Pi liberated. ATPase activity of
intact mitochondria was assayed at 30‡C in the presence or absence of
1.0 WM FCCP, the reaction medium consisting of 50.0 mM sucrose,
120.0 mM Tris-HCl, pH 7.4, 50.0 mM KCl, 3.0 mM ATP, and 3.0 mg
of mitochondrial protein. Liberated orthophosphate was measured
according to Summer [19] and the results expressed as nmols of Pi
liberated per min per mg.
2.6. Measurements of mitochondrial transmembrane electrical potential
(v8)
The transmembrane potential was evaluated at 30‡C with safranine
O [20]. The standard reaction medium consisted of 250.0 mM man-
nitol, 10.0 mM HEPES, pH 7.2, and was supplemented with 0.5 mM
Pi, 10.0 WM safranine O, 1.5 mg of mitochondrial protein, 3.0 mM
sodium succinate and 4.0 WM rotenone. When sodium glutamate (6.0
mM) was used as substrate, rotenone was omitted. Absorbance at
511^533 nm was registered in an Aminco Chance dual wavelength
beam recording spectrophotometer, and the transmembrane electrical
potential (vi) estimated as described by Rossi and Azzoni [21].
2.7. Protein determinations
Mitochondrial protein was assayed by the method of Lowry et al.
[22], using bovine serum albumin as standard.
2.8. Statistical analysis
Statistical analysis of the data was carried out as analysis of var-
iance and test of Tukey for average comparison. Mean values þ S.D.
were used.
3. Results and discussion
Fig. 2 shows the e¡ect of various concentrations of MI-D
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Fig. 1. Chemical structure of 4-phenyl-5-(4-nitrocinnamoyl)-1,3,4-
thiadiazolium-2-phenylamine chloride.
Fig. 2. E¡ects of MI-D on mitochondrial respiration with sodium glutamate (a) or sodium succinate (b) as substrate. Conditions for oxygen
uptake measurements are described in Section 2. A: State III, mitochondrial oxygen uptake in the presence of ADP and substrate. 100% activ-
ity corresponds to 34.6 þ 4.2 and 38.0 þ 4.0 nmol of oxygen consumed per min per mg of mitochondrial protein for glutamate and succinate, re-
spectively. B: State IV, mitochondrial oxygen uptake after exhaustion of ADP. 100% activity corresponds to 7.0 þ 1.1 and 8.0 þ 1.3 nmol of
oxygen consumed per min per mg of protein for glutamate and succinate, respectively. C: RCC, respiratory control coe⁄cient. 100% corre-
sponds to 4.6 þ .0.2 and 4.6 þ 0.6 for glutamate and succinate, respectively. D: ADP/O, ADP concentration/oxygen consumption. 100% corre-
sponds to values of 2.8 þ 0.2 and 1.8 þ .0.2 for glutamate and succinate, respectively. Each value represents the mean þ S.D. of six di¡erent ex-
periments. *Signi¢cantly di¡erent from control (P6 0.05).
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on the respiratory parameters of functionally intact mitochon-
dria. In these experiments, glutamate and succinate were the
oxidizable substrates and the analyzed parameters were: (i)
the rates of oxygen consumption in states III (Fig. 2A) and
IV (Fig. 2B) of mitochondrial respiration; (ii) the respiratory
control coe⁄cient (RC) (Fig. 2C); and (iii) the ADP/O ratio
(Fig. 2D). In Fig. 2A it can be observed that the e¡ect of MI-
D on preparations of mitochondria respiring in the presence
of substrates and ADP (state III) was discrete for both sub-
strates, besides not being identical. When glutamate was used,
MI-D at 15.0 nmol/mg protein promoted a slight but statisti-
cally signi¢cant increase in the respiratory rate, but with a
decrease (22%) when 65.0 nmol MI-D/mg protein was used.
When succinate was the substrate, the e¡ect of MI-D on state
III was inhibitory (30%), up to 25.0 nmol/mg protein. In con-
trast, as can be seen in Fig. 2B, the rate of oxygen consump-
tion after ADP exhaustion (state IV) was strongly increased
reaching 80.0 nmol/mg protein, a stimulus of 190% and 152%
during oxidation of glutamate and succinate, respectively (Fig.
2B). The values for RC and ADP/O ratios were lower (Fig.
2C and D), indicating that MI-D could, in addition to an
e¡ect on components of respiratory chain, give rise to an
accentuated uncoupler e¡ect.
In order to clarify the e¡ects of MI-D on state III respira-
tion, assays were carried out using broken mitochondria.
Under this experimental condition, an evaluation could be
made of electron transport throughout the respiratory chain,
independent of the membrane barrier, phosphorylation activ-
ity or other processes dependent on v8 ; in addition, a deter-
mination could be performed of the site of respiratory chain
inhibition. The presence of the drug in the system decreased
the activities of NADH and succinate oxidase by 32% and
55%, respectively. The segments of the respiratory chain,
namely NADH-cytochrome c reductase, succinate-cytochrome
c reductase, as well as succinate dehydrogenase were inhibited
by 20%. No e¡ect was observed on NADH dehydrogenase
and cytochrome oxidase, suggesting that the site of MI-D
inhibition is further on than complex I and between com-
plexes II and III. These results explain those pointed out by
Fig. 2A, in terms of a decrease of oxygen consumption at
state III. Small di¡erences in inhibition values could signify
particular properties of the mitochondrial preparations used,
especially considering that in broken mitochondria the dis-
rupted membrane barrier could allow direct interaction of
MI-D with the enzymatic complexes.
Fig. 3 shows that MI-D impairs the development of v8 by
mitochondria energized with succinate or glutamate, the con-
centration of the drug for total potential collapse being di¡er-
ent for each substrate. While 65.0 nmol/mg protein was su⁄-
cient to abolish v8 completely when glutamate was the
substrate, with succinate a decrease of 40% was observed at
80.0 nmol/mg protein. The di¡erent magnitude e¡ects could
be results of the mechanism by which each substrate had
access into the mitochondria; glutamate depended on the
vpH across the inner mitochondrial membrane, while succi-
nate depended on the dicarboxylate carrier [23]. The e¡ects
promoted by MI-D on v8 must be related with its uncoupling
property, since its e¡ect as inhibitor of electron transport was
not su⁄cient to explain the drastic collapse of the transmem-
brane potential observed.
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Fig. 3. E¡ect of MI-D on vi. Rat liver mitochondria (1.5 mg) was
incubated under the standard incubation conditions, as described in
Section 2 and energized with sodium glutamate (a) or sodium succi-
nate (b). Each value represents the mean þ S.D. of four di¡erent ex-
periments. *Values signi¢cantly di¡erent relative to absence of MI-
D (P6 0.05). 100% corresponds to 170 þ 10.9 mV of transmembrane
electrical potential.
Fig. 4. E¡ects of MI-D on ATPase. (R) Disrupted mitochondria.
100% activity is that of 700.0 þ 112.0 nmol of Pi released per min
per mg of mitochondrial protein. (F) Intact mitochondria. 100% ac-
tivity is that of 20.0 þ 1.1 nmol of Pi released per min per mg of mi-
tochondrial protein. (E) FCCP-uncoupled mitochondria. 100% activ-
ity is that of 91.3 þ 5.6 nmol of Pi released per min per mg of
mitochondrial protein. The assay conditions are described in Section
2. The data are the means þ S.D. of four di¡erent experiments. *Sig-
ni¢cantly di¡erent from control (P6 0.05).
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In order to better visualize the uncoupler action of MI-D,
the e¡ect of this xenobiotic was evaluated on ATPase activity;
the results are shown in Fig. 4. In these experiments the en-
zyme was assayed in preparations consisting of disrupted, in-
tact and FCCP-uncoupled mitochondria. This last condition
was included considering the reports that excess or simulta-
neous combinations of uncoupler agents might result in sub-
maximal rates of mitochondrial parameters as a decrease of
ATP hydrolysis [24] and/or oxygen consumption [25]. No ef-
fect on ATPase activity was detected when MI-D was eval-
uated using disrupted mitochondria preparations, excluding a
direct interference of this drug on the enzyme. In contrast, as
would be expected for an uncoupler agent, MI-D promoted a
strong stimulus on the hydrolytic activity of ATPase, assayed
in intact mitochondria. This stimulus was dependent on MI-D
concentration and reached 300% at 160.0 nmol/mg protein. A
further increase in drug concentration, up to 240.0 nmol/mg
protein, was accompanied by an accentuated decrease of ATP
hydrolysis. This has also been described for compounds such
as 2,4-dinitrophenol (DNP) [26] and FCCP [27], when used in
concentrations higher than those necessary for uncoupling
mitochondria. The e¡ect of MI-D, as evaluated on ATPase
of FCCP-treated mitochondria, was inhibitory (Fig. 4). In
addition, MI-D was able to remove the inhibition caused by
oligomicin (data not shown). These results characterize and
include MI-D as a new uncoupler agent, although of lower
potency than FCCP, and suggest that the e¡ects of this xeno-
biotic depend on its interaction with membrane constituents.
In this context it has been shown that both membrane lipids
and proteins change simultaneously during the uncoupling
event [28]. Speci¢c interactions with membrane polypeptides,
similar to those described for analogues of the classical un-
couplers DNP and FCCP [29,30] and also suggested from
studies with recoupling agents [31], could be involved during
the interaction of MI-D with the membrane. In order to deal
with this possibility, experiments of £uorescence polarization
developed in our laboratory with dimyristoylphosphatidylcho-
line (DMPC) liposomes (data not shown), have pointed to a
distribution of MI-D molecules in both phospholipid bilayer
region and phospholipid/water interface, as described for un-
coupler agents [32].
The actions of MI-D on mitochondria are complex with a
diverse spectrum of responses being manifested. While MI-D
satis¢es most, if not all of the criteria for an uncoupler agent,
at higher concentrations it can act as electron transport inhib-
itor. An inhibition of state III, particularly when succinate
was the substrate, became evident within the stimulatory con-
centration range of state IV. Compounds with such properties
have been classi¢ed as inhibitory uncouplers [33]. The e¡ects
of MI-D on the mitochondria were in close relationship with
its structural properties, the bulky hydrophobic groups, in
addition to the presence of an acid-dissociable group, justify-
ing all the presently observed results.
In a recent review Skulachev [34] pointed that in some in-
stances an uncoupling action could explain the therapeutic
e¡ect of a drug. This seems true for the antitumor action of
carbonylcyanide-m-chlorophenylhydrazone (CCCP) [35] and
other anticancer drugs [36]. In this respect, the results pre-
sented herein could be involved in the antitumor activity of
MI-D described by Grynberg et al. [10].
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